Erb C - Search Results

1

Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.

Hartmann J, Erb C, Ebert U, Baumann KH, Popp A, König G, Klein J. Hartmann J, et al. Among authors: erb c. Neuroscience. 2004;125(4):1009-17. doi: 10.1016/j.neuroscience.2004.02.038. Neuroscience. 2004. PMID: 15120860

2

Modulation of hippocampal acetylcholine release after fimbria-fornix lesions and septal transplantation in rats.

Erb C, Klein J, Köppen A, Löffelholz K, Jeltsch H, Cassel JC. Erb C, et al. Neurosci Lett. 1997 Aug 1;231(1):5-8. doi: 10.1016/s0304-3940(97)00504-1. Neurosci Lett. 1997. PMID: 9280154

3

Enhancement of brain choline levels by nicotinamide: mechanism of action.

Erb C, Klein J. Erb C, et al. Neurosci Lett. 1998 Jun 19;249(2-3):111-4. doi: 10.1016/s0304-3940(98)00418-2. Neurosci Lett. 1998. PMID: 9682829

4

Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase.

Erb C, Troost J, Kopf S, Schmitt U, Löffelholz K, Soreq H, Klein J. Erb C, et al. J Neurochem. 2001 Apr;77(2):638-46. doi: 10.1046/j.1471-4159.2001.00287.x. J Neurochem. 2001. PMID: 11299326 Free article.

5

Acetylcholine release and choline availability in rat hippocampus: effects of exogenous choline and nicotinamide.

Köppen A, Klein J, Erb C, Löffelholz K. Köppen A, et al. Among authors: erb c. J Pharmacol Exp Ther. 1997 Sep;282(3):1139-45. J Pharmacol Exp Ther. 1997. PMID: 9316819

6

Formation of N-methylnicotinamide in the brain from a dihydropyridine-type prodrug: effect on brain choline.

Erb C, Seidel A, Frank H, Platt KL, Oesch F, Klein J. Erb C, et al. Biochem Pharmacol. 1999 Mar 15;57(6):681-4. doi: 10.1016/s0006-2952(98)00338-4. Biochem Pharmacol. 1999. PMID: 10037454

7

Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist.

Boess FG, de Vry J, Erb C, Flessner T, Hendrix M, Luithle J, Methfessel C, Schnizler K, van der Staay FJ, van Kampen M, Wiese WB, König G. Boess FG, et al. Among authors: erb c. Psychopharmacology (Berl). 2013 May;227(1):1-17. doi: 10.1007/s00213-012-2933-4. Epub 2012 Dec 16. Psychopharmacology (Berl). 2013. PMID: 23241647

8

The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents.

van der Staay FJ, Rutten K, Bärfacker L, Devry J, Erb C, Heckroth H, Karthaus D, Tersteegen A, van Kampen M, Blokland A, Prickaerts J, Reymann KG, Schröder UH, Hendrix M. van der Staay FJ, et al. Among authors: erb c. Neuropharmacology. 2008 Oct;55(5):908-18. doi: 10.1016/j.neuropharm.2008.07.005. Epub 2008 Jul 12. Neuropharmacology. 2008. PMID: 18674549

9

Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance.

Boess FG, Hendrix M, van der Staay FJ, Erb C, Schreiber R, van Staveren W, de Vente J, Prickaerts J, Blokland A, Koenig G. Boess FG, et al. Among authors: erb c. Neuropharmacology. 2004 Dec;47(7):1081-92. doi: 10.1016/j.neuropharm.2004.07.040. Neuropharmacology. 2004. PMID: 15555642

10

The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents.

Boess FG, De Vry J, Erb C, Flessner T, Hendrix M, Luithle J, Methfessel C, Riedl B, Schnizler K, van der Staay FJ, van Kampen M, Wiese WB, Koenig G. Boess FG, et al. Among authors: erb c. J Pharmacol Exp Ther. 2007 May;321(2):716-25. doi: 10.1124/jpet.106.118976. Epub 2007 Feb 16. J Pharmacol Exp Ther. 2007. PMID: 17308038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page